Answers are grounded in this paper and cite their sources.
This analysis identifies inhibited pathways related to adverse drug reactions, indicating further validation is needed.
Our approach identifies plausible inhibited pathways, raising awareness that a high burden of pathway inhibition can contribute to the occurrence of ADRs. Further validation in a second dataset is necessary.
No takes yet. Share an insight, caveat, or question.
Berres et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: